Kairos Pharma Ltd. (KAPA)
Market Closed
15 Oct, 08:00 PM
AMEX AMEX Primary $
0. 67
-0.07
-9.7443%
$
2.48M Market Cap
- P/E Ratio
- Div Yield
253,078 Volume
0 Eps
$ 0.74
Previous Close Want to track KAPA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kairos Pharma Ltd. (KAPA) Statistics
Valuation metrics
Market Cap 2.48M
Enterprise value -147.5K
Trailing P/E (ttm) -0.42
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 0.59
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.03
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 920.92K
Average volume (90 days) 1.81M
Price summary
52-Week low 0.66
52-Week high 9.17
Beta -
50-Day moving average 1.38
200-Day moving average 0.69
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:7
Last split Date 1 Sep 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.3%
Return on equity -0.99%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.9
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.86
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 11.98%
Book value per share (mrq) 1.37
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
